Financial Network Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Financial Network Wealth Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.79K	Hold	14	–	–	﹤0.01%	618
2025 Q4	$2.65K	Sell	14 -10	-42%	-$1.92K	﹤0.01%	627
2025 Q3	$4.25K	Hold	24	–	–	﹤0.01%	545
2025 Q2	$2.73K	Sell	24 -1	-4%	-$107	﹤0.01%	595
2025 Q1	$2.63K	Buy	+25	New	+$2.83K	﹤0.01%	555
2024 Q4	–	Sell	-25	Closed	-$2.5K	–	682
2024 Q3	$2.5K	Buy	25 +4	+19%	+$403	﹤0.01%	607
2024 Q2	$1.77K	Buy	+21	New	+$1.67K	﹤0.01%	760

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Financial Network Wealth Advisors's LGND Position: Q1 2026 in Review

Financial Network Wealth Advisors held its Ligand Pharmaceuticals (LGND) position steady in Q1 2026 at 14 shares worth $2.79K. The position accounts for ﹤0.01% of the portfolio, ranked #618.

Financial Network Wealth Advisors first reported a position in LGND in Q2 2024 and has held it in 7 quarters since. The position peaked at $4.25K in Q3 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

Financial Network Wealth Advisors held 14 shares of Ligand Pharmaceuticals worth $2.79K as of Q1 2026.
Financial Network Wealth Advisors left its Ligand Pharmaceuticals share count unchanged in Q1 2026.
Ligand Pharmaceuticals made up ﹤0.01% of Financial Network Wealth Advisors's portfolio in Q1 2026, its #618 holding.
Financial Network Wealth Advisors first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
Financial Network Wealth Advisors's Ligand Pharmaceuticals position peaked at $4.25K in Q3 2025.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.